Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2004
11/11/2004WO2004097040A1 Method for the detection of infectious positive-strand rna viruses, especially infectious enteroviruses
11/11/2004WO2004097039A2 Biosynthetic platform for cardioprotective gene expression using neonatal immature and fetal heart tissue
11/11/2004WO2004097038A1 Methods for identifying and managing livestock by genotype
11/11/2004WO2004097037A1 Microorganism staining agent and use thereof
11/11/2004WO2004097036A2 Optical detector for enzyme activation
11/11/2004WO2004097035A1 Electrochemical sensing assays involving drug metabolising enzymers
11/11/2004WO2004097034A2 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 4 (tmprss4)
11/11/2004WO2004097033A1 Serum biomarkers of hepatitis b virus infected liver and methods for detection thereof
11/11/2004WO2004097032A2 Method for nucleic acid sequencing
11/11/2004WO2004097031A2 Methods for detecting methylated promoters based on differential dna methylation
11/11/2004WO2004097030A2 Prognostic breast cancer biomarkers
11/11/2004WO2004097029A2 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
11/11/2004WO2004097028A2 Discovery of biocatalysts and biocatalytic activities using nuclear magnetic resonance and deuterium
11/11/2004WO2004097021A1 Nucleic acid detection
11/11/2004WO2004097015A1 Array having substances fixed on support arranged with chromosomal order or sequence position information added thereto, process for producing the same, analytical system using the array and use of these
11/11/2004WO2004097005A2 Global analysis of transposable elements as molecular markers of the developmental potential of stem cells
11/11/2004WO2004097003A2 Multiply-primed amplification of nucleic acid sequences
11/11/2004WO2004096999A2 In vitro translation system
11/11/2004WO2004096997A2 Molecular detection systems utilizing reiterative oligonucleotide synthesis
11/11/2004WO2004096995A2 Recombinant plant dicer
11/11/2004WO2004096992A2 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
11/11/2004WO2004096991A2 Bcl2l12 polypeptide activators and inhibitors
11/11/2004WO2004096987A2 A forward mutation assay based on 5-fluorouracil resistance
11/11/2004WO2004096986A2 Method for quantitative detection of nucleic acid molecules
11/11/2004WO2004096985A2 Methods for assessing biologic diversity
11/11/2004WO2004096984A2 Preservation of rna in a biological sample
11/11/2004WO2004096980A2 Novel polynucleotides encoding soluble polypeptides and methods using same
11/11/2004WO2004096979A2 Methods and systems for annotating biomolecular sequences
11/11/2004WO2004096832A2 Novel antiangiogenic peptides
11/11/2004WO2004096825A1 Treatment of nucleic acid
11/11/2004WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004WO2004096246A1 Antiallergic composition
11/11/2004WO2004096183A1 Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
11/11/2004WO2004096054A1 Method for detecting pathogenic agents
11/11/2004WO2004096021A2 Global analysis of transposable elements as molecular markers of cancer
11/11/2004WO2004096020A2 Method for detection and characterization of pre-malignant transformation
11/11/2004WO2004083367A3 Lyophilised cells and a method of lyophilisation for the production of said cells
11/11/2004WO2004080202A3 Production of plants with improved digestibility having an inactive peroxidase
11/11/2004WO2004079332A3 Composition and method for increasing efficiency of introduction of target substance into cell
11/11/2004WO2004078997A3 Method for detecting micro-organisms in an electrocoating process
11/11/2004WO2004078713A3 Morpholino based activity mapping
11/11/2004WO2004076054A3 Dry chemistry, lateral flow-reconstituted chromatographic enzyme-driven assays
11/11/2004WO2004075833A3 Methods of determining a chemotherapeutic regimen based on loss of heterozygosity at the thymidylate synthase locus
11/11/2004WO2004071377A3 Diagnostics and therapeutics for diseases associated with phosphodiesterase 3a (pde3a)
11/11/2004WO2004070005A3 Double ended sequencing
11/11/2004WO2004068139A3 Improvement of catalytic efficiency and/or specificity of non-native substrates of enzymes
11/11/2004WO2004066949A8 Antisense oligonucleotides that inhibit expression of hif-1
11/11/2004WO2004064773A3 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders
11/11/2004WO2004061119A3 Rolling circle amplification of rna
11/11/2004WO2004055202A3 Screening method for identifying substances active against halitosis, gingivitis or parodontitis
11/11/2004WO2004052175A3 Methods for rapid identification of pathogens in humans and animals
11/11/2004WO2004048973A8 Method of fixing biomolecule on metal support
11/11/2004WO2004048583A3 Compositions and systems for the regulation of genes
11/11/2004WO2004048528A3 Sampling method and apparatus for amplification reaction analysis
11/11/2004WO2004043230A3 A method of screening for disorders of glucose metabolism
11/11/2004WO2004038367A3 Biological assays using gradients formed in microfluidic systems
11/11/2004WO2004038037A3 Controlled alignment of nano-barcodes encoding specific information for scanning probe microscopy (spm) reading
11/11/2004WO2004034027A3 Method for sizing polynucleotides using electrophoresis with non-dna size standards
11/11/2004WO2004033721A3 Hybridization samples having a reduced complexity
11/11/2004WO2004027384A3 Real-time detection of nucleic acid reactions
11/11/2004WO2004024941A3 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
11/11/2004WO2004020458A3 Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents
11/11/2004WO2004020453A3 Functionalized nanoparticles
11/11/2004WO2004015070A3 Isolation and identification of t cells
11/11/2004WO2004011625A3 Polymorphisms for predicting disease and treatment outcome
11/11/2004WO2004010108A3 Method for the identification of ligands
11/11/2004WO2004009799A3 Ion channel receptor and uses thereof
11/11/2004WO2004009773A3 Methods and compositions for activating or inhibiting vegf-d and vegf-c
11/11/2004WO2004008841A3 Dna fingerprinting for cannabis sativa (marijuana) using short tandem repeat (str) markers
11/11/2004WO2003104770A3 A disposable cartridge for characterizing particles suspended in a liquid
11/11/2004WO2003102166A8 Novel flavivirus antigens
11/11/2004WO2003101394A3 Defensins: use as antiviral agents
11/11/2004WO2003088125A8 System and method for integrated computer-aided molecular discovery
11/11/2004WO2003087051B1 Methods for identifying allosteric sites
11/11/2004WO2003079982A3 Gene amplification in cancer
11/11/2004WO2003060150A8 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
11/11/2004WO2003038052A3 Nucleic acid-associated proteins
11/11/2004WO2003035890A3 Glioblastoma multiforme associated protein gliten
11/11/2004WO2003012068A3 Novel fusion proteins and assays for molecular binding
11/11/2004US20040226060 Method for obtaining a plant with a lasting resistance to a pathogen
11/11/2004US20040226055 Animal model exhibiting pathological conditions of Alzheimer's disease
11/11/2004US20040225456 Chemical structure identification
11/11/2004US20040225450 Analysis of substrates exposed to tobacco and components derived from tobacco
11/11/2004US20040225119 Fluorescent dyes for use as diagnostic/signalling tool in nucleotide sequence analysis
11/11/2004US20040225118 31 human secreted proteins
11/11/2004US20040225114 IGF-1 receptor interacting proteins
11/11/2004US20040225000 4-(R'-Imino)-3-Mercapto-5-(R)4H-1,2,4-Triazols, 4-(R'-imino)-3-alkylthio-5-R-1,2,4-triazoles and 4-amino-3-mercapto-triazoles as inhibitors of nitric oxide synthase (NOS) and as inhibitors of malignant cell growth
11/11/2004US20040224915 High affinity vascular endothelial growth factor(VEGF) receptor nucleic acid ligands and inhibitors
11/11/2004US20040224911 Transporters and ion channels
11/11/2004US20040224910 Recombinant nematode nicotinic receptor and uses
11/11/2004US20040224898 inducing lypolysis using a nucleic acid expression vector coding for an insect adipokinetic hormone polypeptide; cyclization and amidation; dietetics; drug screening
11/11/2004US20040224891 Methods for the early diagnosis of ovarian cancer
11/11/2004US20040224881 drug screening for chloride channel blockers; osteoporosis, osteolytic cancer, osteopetrosis, Paget's disease; anticarcinogenic agents
11/11/2004US20040224424 Nucleotide sequences comprising allelic variant of cytochrome p450 for use in diagnosis and treatment of cell proliferative, nervous system and cardiovascular disorders; pharmacodynamic profiles and drug screening
11/11/2004US20040224411 Transgenic cell comprising adenoviral vector for use as gene delivery tool; tissue engineering heterologous gene expression; DNA vaccines
11/11/2004US20040224407 Expression vector for consistent cellular expression of the tet on repressor in multiple cell types
11/11/2004US20040224388 Hyphal growth in fungi
11/11/2004US20040224386 Protein tyrosine kinases
11/11/2004US20040224379 Using tetramitus rostratus, a flagellate particle feeding microorganism, to detect toxins in air, water or other solid, liquid or gaseous samples; biological and chemical warfare screening
11/11/2004US20040224378 Methods for using ADAMTS-12, an integrin and metalloprotease with thrombspondin motifs